A Label‐Free Hyperspectral Imaging Device for Ex Vivo Characterization and Grading of Meningioma Tissues
Journal of Biophotonics · 2026-03 · 19 (3)
DOI: 10.1002/jbio.202500374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biophotonics, online erschienen am 15.12.2025. Verfasst von Pietro Ricci und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Astronomy, University of Florence, Sesto Fiorentino, Italy. Hauptthemen laut MEDLINE: Meningioma, Hyperspectral Imaging, Meningeal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Innovation Council - Horizon Europe, UK Research and Innovation (UKRI), Italian Ministry for University and Research - Euro-Bioimaging ERIC.
Abstract (Originalsprache)
Histopathology remains the gold standard for definitive tumor diagnosis after surgical resection; however, its lengthy processing time can delay critical postoperative care. Hyperspectral imaging (HSI) is emerging as a promising label‐free technique for rapid biochemical tissue assessment. Here, we present HyperProbe1.1 (HP1.1), an HSI system designed for noninvasive analysis of fresh brain tumor biopsies. In this proof‐of‐concept study, we applied the HP1.1 system to freshly excised meningioma specimens—the most common primary intracranial tumors. The platform enabled rapid, label‐free mapping of metabolic activity and vascular heterogeneity, while spectral unmixing further allowed the quantification of endogenous biomarkers such as cytochrome c oxidase (CCO), hemoglobin derivatives, and lipids, revealing molecular patterns consistent with histopathological tumor grading according to the 2021 WHO classification. These results highlight the feasibility of HSI for rapid biochemical tissue assessment and its potential integration into intraoperative decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physics and Astronomy, University of Florence, Sesto Fiorentino, Italy.
- European Laboratory for Non-Linear Spectroscopy, Sesto Fiorentino, Italy.
- Neurosurgery, Department of Neuroscience, Psychology, Pharmacology and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
- Klinikum Rechts der Isar, Technischen Universität München, Munich, Germany.
- Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy.
- Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
ORCID-Profile: Filippo Nozzoli
Förderung
- European Innovation Council - Horizon Europe
- UK Research and Innovation (UKRI)
- Italian Ministry for University and Research - Euro-Bioimaging ERIC
Zitieren
APA
Ricci, P., Bonaudo, C., Ezhov, I., Toaha, A., Nardini, D., Camelia, M., Lucidi, F., Nozzoli, F., Mach, T., Tachtsidis, I., Rueckert, D., Della Puppa, A., Giannoni, L., & Pavone, F. S. (2026). A Label‐Free Hyperspectral Imaging Device for Ex Vivo Characterization and Grading of Meningioma Tissues. Journal of Biophotonics, 19(3). https://doi.org/10.1002/jbio.202500374
Vancouver
Ricci P, Bonaudo C, Ezhov I, Toaha A, Nardini D, Camelia M, et al. A Label‐Free Hyperspectral Imaging Device for Ex Vivo Characterization and Grading of Meningioma Tissues. Journal of Biophotonics. 2026;19(3). doi:10.1002/jbio.202500374
BibTeX
@article{Ricci2026,
author = {Ricci, Pietro and Bonaudo, Camilla and Ezhov, Ivan and Toaha, Anam and Nardini, Dorotea and Camelia, Manuel and Lucidi, Federica and Nozzoli, Filippo and Mach, Tim and Tachtsidis, Ilias and Rueckert, Daniel and Della Puppa, Alessandro and Giannoni, Luca and Pavone, Francesco S},
title = {A Label‐Free Hyperspectral Imaging Device for Ex Vivo Characterization and Grading of Meningioma Tissues},
journal = {Journal of Biophotonics},
year = {2026},
volume = {19},
number = {3},
doi = {10.1002/jbio.202500374}
}
EUVIMED